Skip to content

Study of Sinomenine Hydrochloride in the treatment of rheumatoid arthritis

Study of Sinomenine Hydrochloride in the treatment of rheumatoid arthritis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007415
Enrollment
Unknown
Registered
2015-11-19
Start date
2015-11-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

treatment group:sinomenine hydrochloride combined with MTX
controlled group:LEF combined with MTX

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient must meet 1987 American College of Rheumatology classification criteria for the diagnosis of active rheumatoid arthritis and/or 2010 American College of Rheumatology /The European League Against Rheumatism classification criteria for the diagnosis of active rheumatoid arthritis; The patients must meet Class I-III of the Xray development in RA; 2. Patient has signed the informed consent; 3. Patient must be between 18 and 65 years of age.

Exclusion criteria

Exclusion criteria: 1. Infection, pregnancy, lactating, traumatic or other stress state; 2. Severe, progressive or uncontrolled cardiac, hepatic, renal, mental disease; 3. Severe hematologic disease including leukemia, aplastic anemia, myelodysplastic syndrome and so on; 4. Be allergic to the medicine we use in the research; 5. Use antibiotics within 1 month; 6. Patients in the Class? of RA; 7. History of other rheumatic autoimmune disease; 8. Patients with active gastrointestinal disease or pitents with peptic ulcer 4 or less weekly; 9. Patients who have previously participated in any clinical study.

Design outcomes

Primary

MeasureTime frame
DAS28;

Countries

China

Contacts

Public ContactQing-chun Huang
qch1963@163.com+86 13922230939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026